Sanara MedTech (SMTI) Stock Forecast, Price & News

0 Wall Street research analysts have issued 1 year price objectives for Sanara MedTech's shares. Their SMTI share price forecasts range from $50.00 to $50.00. On average, they anticipate the company's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 23.4% from the stock's current price.
View analysts price targets for SMTI or view top-rated stocks among Wall Street analysts.

Sanara MedTech's stock was trading at $45.50 on January 1st, 2023. Since then, SMTI shares have decreased by 10.9% and is now trading at $40.52.
View the best growth stocks for 2023 here.

Sanara MedTech saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 62,900 shares, a drop of 14.0% from the April 30th total of 73,100 shares. Based on an average daily trading volume, of 18,200 shares, the short-interest ratio is presently 3.5 days. Currently, 1.9% of the company's stock are sold short.
View Sanara MedTech's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our SMTI earnings forecast.

Sanara MedTech Inc. (NASDAQ:SMTI) posted its earnings results on Monday, March, 20th. The company reported ($0.51) EPS for the quarter. The company earned $15.32 million during the quarter. Sanara MedTech had a negative net margin of 18.67% and a negative trailing twelve-month return on equity of 25.60%.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC).

Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI."

Sanara MedTech's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.35%), Susquehanna International Group LLP (0.30%), Ameriprise Financial Inc. (0.21%), Jane Street Group LLC (0.21%), HRT Financial LP (0.13%) and State Street Corp (0.12%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming.
View institutional ownership trends.

Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SMTI stock can currently be purchased for approximately $40.52.

Sanara MedTech (NASDAQ:SMTI) has a market capitalization of $339.68 million and generates $53.55 million in revenue each year. The company earns $-7,940,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis.

Sanara MedTech's mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The official website for the company is www.wndm.com. The company can be reached via phone at (817) 529-2300 or via email at ir@sanaramedtech.com.